North America Pneumococcal Vaccine Market by Manufacturers, Countries, Type and Application, Forecast to 2022

May 2017 | 115 pages | ID: NFCEEB85F50EN
GlobalInfoResearch

Abstracts

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.

23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).

In this report, the data of China comes from NICPBP (National Institutes for Food and Drug Control).

SCOPE OF THE REPORT:

This report focuses on the Pneumococcal Vaccine in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers

• Pfizer
• GSK
• MSD
• Sanofipasteur
• CDIBP

Market Segment by Countries, covering

• United States
• Canada
• Mexico

Market Segment by Type, covers

• PPSV 23
• PCV 7/13
• PCV 10

Market Segment by Applications, can be divided into

• Child
• Adult

There are 15 Chapters to deeply display the North America Pneumococcal Vaccine market.

Chapter 1, to describe Pneumococcal Vaccine Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Pneumococcal Vaccine, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Pneumococcal Vaccine, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Pneumococcal Vaccine market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Pneumococcal Vaccine Research Findings and Conclusion, Appendix, methodology and data source

Contents

1 MARKET OVERVIEW

1.1 Pneumococcal Vaccine Introduction
1.2 Market Analysis by Type
  1.2.1 PPSV
  1.2.2 PCV 7/13
  1.2.3 PCV
1.3 Market Analysis by Applications
  1.3.1 Child
  1.3.2 Adult
1.4 Market Analysis by Countries
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 Mexico Status and Prospect (2012-2022)
  1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Pfizer
  2.1.1 Profile
  2.1.2 Pneumococcal Vaccine Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Pfizer Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.1.4 Business Overview
  2.1.5 Pfizer News
2.2 GSK
  2.2.1 Profile
  2.2.2 Pneumococcal Vaccine Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 GSK Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.2.4 Business Overview
  2.2.5 GSK News
2.3 MSD
  2.3.1 Profile
  2.3.2 Pneumococcal Vaccine Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 MSD Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.3.4 Business Overview
  2.3.5 MSD News
2.4 Sanofipasteur
  2.4.1 Profile
  2.4.2 Pneumococcal Vaccine Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.4.4 Business Overview
  2.4.5 Sanofipasteur News
2.5 CDIBP
  2.5.1 Profile
  2.5.2 Pneumococcal Vaccine Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 CDIBP Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.5.4 Business Overview
  2.5.5 CDIBP News

3 NORTH AMERICA PNEUMOCOCCAL VACCINE MARKET COMPETITION, BY MANUFACTURER

3.1 North America Pneumococcal Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Pneumococcal Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Pneumococcal Vaccine Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Pneumococcal Vaccine Manufacturer Market Share
  3.4.2 Top 5 Pneumococcal Vaccine Manufacturer Market Share
3.5 Market Competition Trend

4 NORTH AMERICA PNEUMOCOCCAL VACCINE MARKET ANALYSIS BY COUNTRIES

4.1 North America Pneumococcal Vaccine Sales Market Share by Countries
4.2 North America Pneumococcal Vaccine Sales by Countries (2012-2017)
4.3 North America Pneumococcal Vaccine Revenue (Value) by Countries (2012-2017)

5 NORTH AMERICA MARKET SEGMENTATION PNEUMOCOCCAL VACCINE BY TYPE

5.1 North America Pneumococcal Vaccine Sales, Revenue and Market Share by Type (2012-2017)
  5.1.1 North America Pneumococcal Vaccine Sales and Market Share by Type (2012-2017)
  5.1.2 North America Pneumococcal Vaccine Revenue and Market Share by Type (2012-2017)
5.2 PPSV 23 Sales Growth and Price
  5.2.1 North America PPSV 23 Sales Growth (2012-2017)
  5.2.2 North America PPSV 23 Price (2012-2017)
5.3 PCV 7/13 Sales Growth and Price
  5.3.1 North America PCV 7/13 Sales Growth (2012-2017)
  5.3.2 North America PCV 7/13 Price (2012-2017)
5.4 PCV 10 Sales Growth and Price
  5.4.1 North America PCV 10 Sales Growth (2012-2017)
  5.4.2 North America PCV 10 Price (2012-2017)

6 NORTH AMERICA MARKET SEGMENTATION PNEUMOCOCCAL VACCINE BY APPLICATION

6.1 North America Pneumococcal Vaccine Sales Market Share by Application (2012-2017)
6.2 Child Sales Growth (2012-2017)
6.3 Adult Sales Growth (2012-2017)

7 UNITED STATES PNEUMOCOCCAL VACCINE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 United States Pneumococcal Vaccine Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Pneumococcal Vaccine Sales and Market Share by Type
7.3 United States Pneumococcal Vaccine Sales by Application (2012-2017)
7.4 United States Pneumococcal Vaccine Sales, Revenue and Market Share by Manufacturer
  7.4.1 United States Pneumococcal Vaccine Sales and Market Share by Manufacturer
  7.4.2 United States Pneumococcal Vaccine Revenue and Market Share by Manufacturer
7.5 United States Pneumococcal Vaccine Export and Import (2012-2017)

8 CANADA PNEUMOCOCCAL VACCINE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 Canada Pneumococcal Vaccine Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Pneumococcal Vaccine Sales and Market Share by Type
8.3 Canada Pneumococcal Vaccine Sales by Application (2012-2017)
8.4 Canada Pneumococcal Vaccine Sales, Revenue and Market Share by Manufacturer
  8.4.1 Canada Pneumococcal Vaccine Sales and Market Share by Manufacturer
  8.4.2 Canada Pneumococcal Vaccine Revenue and Market Share by Manufacturer
8.5 Canada Pneumococcal Vaccine Export and Import (2012-2017)

9 MEXICO PNEUMOCOCCAL VACCINE SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Mexico Pneumococcal Vaccine Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Pneumococcal Vaccine Sales and Market Share by Type
9.3 Mexico Pneumococcal Vaccine Sales by Application (2012-2017)
9.4 Mexico Pneumococcal Vaccine Sales, Revenue and Market Share by Manufacturer
  9.4.1 Mexico Pneumococcal Vaccine Sales and Market Share by Manufacturer
  9.4.2 Mexico Pneumococcal Vaccine Revenue and Market Share by Manufacturer
9.5 Mexico Pneumococcal Vaccine Export and Import (2012-2017)

10 PNEUMOCOCCAL VACCINE MARKET FORECAST (2017-2022)

10.1 North America Pneumococcal Vaccine Sales, Revenue and Growth Rate (2017-2022)
10.2 Pneumococcal Vaccine Market Forecast by Countries (2017-2022)
  10.2.1 United States Pneumococcal Vaccine Forecast (2017-2022)
  10.2.2 Canada Pneumococcal Vaccine Forecast (2017-2022)
  10.2.3 Mexico Pneumococcal Vaccine Forecast (2017-2022)
10.3 Pneumococcal Vaccine Market Forecast by Type (2017-2022)
10.4 Pneumococcal Vaccine Market Forecast by Application (2017-2022)

11 PNEUMOCOCCAL VACCINE MANUFACTURING COST ANALYSIS

11.1 Pneumococcal Vaccine Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Pneumococcal Vaccine

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Pneumococcal Vaccine Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Pneumococcal Vaccine Major Manufacturers in 2016
12.4 Downstream Buyers

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Pneumococcal Vaccine Picture
Table Product Specifications of Pneumococcal Vaccine
Figure North America Sales Market Share of Pneumococcal Vaccine by Types in 2016
Table Types of Pneumococcal Vaccine
Figure PPSV 23 Picture
Table Major Manufacturers of PPSV
Figure PCV 7/13 Picture
Table Major Manufacturers of PCV 7/13
Figure PCV 10 Picture
Table Major Manufacturers of PCV
Table North America Pneumococcal Vaccine Sales Market Share by Applications in 2016
Table Applications of Pneumococcal Vaccine
Figure Child Picture
Figure Adult Picture
Figure United States Pneumococcal Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Pneumococcal Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Pneumococcal Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Pneumococcal Vaccine Type and Applications
Table Pfizer Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Pneumococcal Vaccine Type and Applications
Table GSK Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table MSD Basic Information, Manufacturing Base and Competitors
Table MSD Pneumococcal Vaccine Type and Applications
Table MSD Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofipasteur Basic Information, Manufacturing Base and Competitors
Table Sanofipasteur Pneumococcal Vaccine Type and Applications
Table Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CDIBP Basic Information, Manufacturing Base and Competitors
Table CDIBP Pneumococcal Vaccine Type and Applications
Table CDIBP Pneumococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Pneumococcal Vaccine Sales by Manufacturer (2016-2017)
Figure North America Pneumococcal Vaccine Sales Market Share by Manufacturer in 2016
Figure North America Pneumococcal Vaccine Sales Market Share by Manufacturer in 2017
Table North America Pneumococcal Vaccine Revenue by Manufacturer (2016-2017)
Figure North America Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2016
Figure North America Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2017
Table North America Pneumococcal Vaccine Price by Manufacturers (2016-2017)
Figure Top 3 Pneumococcal Vaccine Manufacturer Market Share in 2016
Figure Top 3 Pneumococcal Vaccine Manufacturer Market Share in 2017
Figure Top 5 Pneumococcal Vaccine Manufacturer Market Share in 2016
Figure Top 5 Pneumococcal Vaccine Manufacturer Market Share in 2017
Figure North America Pneumococcal Vaccine Sales and Growth (2012-2017)
Table North America Pneumococcal Vaccine Sales by Countries (2012-2017)
Table North America Pneumococcal Vaccine Sales Market Share by Countries (2012-2017)
Figure North America 2012 Pneumococcal Vaccine Sales Market Share by Countries
Figure North America 2016 Pneumococcal Vaccine Sales Market Share by Countries
Figure North America Pneumococcal Vaccine Revenue and Growth (2012-2017)
Table North America Pneumococcal Vaccine Revenue by Countries (2012-2017)
Table North America Pneumococcal Vaccine Revenue Market Share by Countries (2012-2017)
Table North America 2012 Pneumococcal Vaccine Revenue Market Share by Countries
Table North America 2016 Pneumococcal Vaccine Revenue Market Share by Countries
Table North America Pneumococcal Vaccine Sales by Type (2012-2017)
Table North America Pneumococcal Vaccine Sales Share by Type (2012-2017)
Table North America Pneumococcal Vaccine Revenue by Type (2012-2017)
Table North America Pneumococcal Vaccine Revenue Share by Type (2012-2017)
Figure North America PPSV 23 Sales Growth (2012-2017)
Figure North America PPSV 23 Price (2012-2017)
Figure North America PCV 7/13 Sales Growth (2012-2017)
Figure North America PCV 7/13 Price (2012-2017)
Figure North America PCV 10 Sales Growth (2012-2017)
Figure North America PCV 10 Price (2012-2017)
Table North America Pneumococcal Vaccine Sales by Application (2012-2017)
Table North America Pneumococcal Vaccine Sales Share by Application (2012-2017)
Figure North America Child Sales Growth (2012-2017)
Figure North America Adult Sales Growth (2012-2017)
Figure United States Pneumococcal Vaccine Revenue and Growth (2012-2017)
Figure United States Pneumococcal Vaccine Sales and Growth (2012-2017)
Table United States Pneumococcal Vaccine Sales by Type (2012-2017)
Table United States Pneumococcal Vaccine Sales Market Share by Type (2012-2017)
Table United States Pneumococcal Vaccine Sales by Application (2012-2017)
Table United States Pneumococcal Vaccine Sales Market Share by Application (2012-2017)
Table United States Pneumococcal Vaccine Sales by Manufacturer (2016-2017)
Figure United States Pneumococcal Vaccine Sales Market Share by Manufacturer in 2016
Figure United States Pneumococcal Vaccine Sales Market Share by Manufacturer in 2017
Table United States Pneumococcal Vaccine Revenue by Manufacturer (2016-2017)
Figure United States Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2016
Figure United States Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2017
Table United States Pneumococcal Vaccine Export and Import (2012-2017)
Figure Canada Pneumococcal Vaccine Revenue and Growth (2012-2017)
Figure Canada Pneumococcal Vaccine Sales and Growth (2012-2017)
Table Canada Pneumococcal Vaccine Sales by Type (2012-2017)
Table Canada Pneumococcal Vaccine Sales Market Share by Type (2012-2017)
Table Canada Pneumococcal Vaccine Sales by Application (2012-2017)
Table Canada Pneumococcal Vaccine Sales Market Share by Application (2012-2017)
Table Canada Pneumococcal Vaccine Sales by Manufacturer (2016-2017)
Figure Canada Pneumococcal Vaccine Sales Market Share by Manufacturer in 2016
Figure Canada Pneumococcal Vaccine Sales Market Share by Manufacturer in 2017
Table Canada Pneumococcal Vaccine Revenue by Manufacturer (2016-2017)
Figure Canada Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2016
Figure Canada Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2017
Table Canada Pneumococcal Vaccine Export and Import (2012-2017)
Figure Mexico Pneumococcal Vaccine Revenue and Growth (2012-2017)
Figure Mexico Pneumococcal Vaccine Sales and Growth (2012-2017)
Table Mexico Pneumococcal Vaccine Sales by Type (2012-2017)
Table Mexico Pneumococcal Vaccine Sales Market Share by Type (2012-2017)
Table Mexico Pneumococcal Vaccine Sales by Application (2012-2017)
Table Mexico Pneumococcal Vaccine Sales Market Share by Application (2012-2017)
Table Mexico Pneumococcal Vaccine Sales by Manufacturer (2016-2017)
Figure Mexico Pneumococcal Vaccine Sales Market Share by Manufacturer in 2016
Figure Mexico Pneumococcal Vaccine Sales Market Share by Manufacturer in 2017
Table Mexico Pneumococcal Vaccine Revenue by Manufacturer (2016-2017)
Figure Mexico Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2016
Figure Mexico Pneumococcal Vaccine Revenue Market Share by Manufacturer in 2017
Table Mexico Pneumococcal Vaccine Export and Import (2012-2017)
Figure North America Pneumococcal Vaccine Sales, Revenue and Growth Rate (2017-2022)
Table North America Pneumococcal Vaccine Sales Forecast by Countries (2017-2022)
Table North America Pneumococcal Vaccine Market Share Forecast by Countries (2017-2022)
Figure United States Pneumococcal Vaccine Sales Forecast (2017-2022)
Figure Canada Pneumococcal Vaccine Sales Forecast (2017-2022)
Figure Mexico Pneumococcal Vaccine Sales Forecast (2017-2022)
Table North America Pneumococcal Vaccine Sales Forecast by Type (2017-2022)
Table North America Pneumococcal Vaccine Market Share Forecast by Type (2017-2022)
Table North America Pneumococcal Vaccine Sales Forecast by Application (2017-2022)
Table North America Pneumococcal Vaccine Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pneumococcal Vaccine
Figure Manufacturing Process Analysis of Pneumococcal Vaccine
Figure Pneumococcal Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Pneumococcal Vaccine Major Manufacturers in 2016
Table Major Buyers of Pneumococcal Vaccine
Table Distributors/Traders/ Dealers List